Johns Hopkins Drug Discovery - Project - Chemotherapy-Induced Neropathy
55
page-template,page-template-full_width,page-template-full_width-php,page,page-id-55,page-child,parent-pageid-19,ajax_fade,page_not_loaded,,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-4.12.1,vc_responsive

Intranasal Insulin

Intranasal insulin may offer a novel treatment for various cognitive disorders including HIV-associated neurocognitive disorders (HAND).1-3  To promote clinical translation of this approach, we recently showed that intranasal administration of insulin improves delivery to the brain relative to subcutaneous dosing, resulting in 2000-fold higher brain to plasma ratios.4  As the Therapeutic Core of the Johns Hopkins NIMH Center for Novel Therapeutics for HAND, we are now working to test the behavioral efficacy of intranasal insulin in a rodent model of HAND.  Efforts to delineate the mechanism of insulin efficacy in HAND are also underway with particular attention being paid to the effect of insulin on energy metabolism in key brain regions, as well as a potential effect on viral load.  These experiments will inform study design and dose selection for a clinical trial of intranasal insulin in HAND patients currently being enrolled at Johns Hopkins.

REFERENCES

  1. Craft S, Asthana S, Newcomer JW, Wilkinson CW, Matos IT, Baker LD, Cherrier M, Lofgreen C, Latendresse S, Petrova A, Plymate S, Raskind M, Grimwood K, Veith RC.  “Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.” Arch. Gen. Psychiatry, 1999, 56, 1135-40. [PubMed]
  2. Mamik MK, Asahchop EL, Chan WF, Zhu Y, Branton WG, McKenzie BA, Cohen EA, Power C. “Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration.” J. Neurosci., 2016, 36, 10683-10695. [PubMed]
  3. Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC. “HIV-associated neurocognitive disorder – pathogenesis and prospects for treatment.” Nat. Rev. Neurol., 2016, 12, 309. [PubMed]
  4. Nedelcovych MT, Gadiano AJ, Wu Y, Manning AA, Thomas AG, Khuder SS, Yoo SW, Xu J, McArthur JC, Haughey NJ, Volsky DJ, Rais R, Slusher BS. “Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse.”  ACS Chem Neurosci, 2018, Jan 4, Epub ahead of print. [PubMed]
lowgo_bottom